Linton, Steven D, Aja, Teresa, Allegrini, Peter Roland, Deckwerth, Thomas L, Diaz, Jose-Luis, Hengerer, Bastian, Herrmann, Julia, Jahangiri, Kathy G, Kallen, Joerg, Karanewsky, Donald S, Meduna, Steven P, Nalley, Kip, Robinson, Edward D, Roggo, Silvio, Rovelli, Giorgio, Sauter, Andre, Sayers, Robert O, Schmitz, Albert, Smidt, Robert, Ternansky, Robert J, Tomaselli, Kevin J, Ullman, Brett R, Wiessner, Christoph and Wu, Joe C (2004) Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke. Bioorganic & Medicinal Chemistry Letters, 14 (10). pp. 2685-2691. ISSN 0960-894X

Abstract

Structural modifications were made to a previously described acyl dipeptide caspase inhibitor, leading to the oxamyl dipeptide series. Subsequent SAR studies directed toward the warhead, P2, and P4 regions of this novel peptidomimetic are described herein.

Item Type:	Article
Related URLs:	http://www.ncbi.nlm.nih.gov/sites/entrez...
Additional Information:	Author can archive post-print (ie final draft post-refereeing); Publisher's version/PDF cannot be used
Related URLs:	http://www.ncbi.nlm.nih.gov/sites/entrez...
Date Deposited:	29 Apr 2010 23:45
Last Modified:	01 Feb 2013 00:49
URI:	https://oak.novartis.com/id/eprint/2860